X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20) 20
index medicus (16) 16
oncology (16) 16
female (14) 14
male (14) 14
middle aged (13) 13
aged (12) 12
adult (11) 11
corrosion (9) 9
biochemistry (7) 7
mln8237 (7) 7
adsorption (6) 6
cancer (6) 6
chemistry (6) 6
aged, 80 and over (5) 5
antineoplastic agents - adverse effects (5) 5
antineoplastic agents - pharmacokinetics (5) 5
aurora kinases (5) 5
azepines - adverse effects (5) 5
beer (5) 5
breast-cancer (5) 5
care and treatment (5) 5
compositions or test papers therefor (5) 5
condition-responsive control in microbiological orenzymological processes (5) 5
enzymology (5) 5
flow cytometry (5) 5
impedance (5) 5
investigating or analysing materials by determining theirchemical or physical properties (5) 5
measuring (5) 5
measuring or testing processes involving enzymes, nucleicacids or microorganisms (5) 5
metallurgy (5) 5
microbiology (5) 5
mutation or genetic engineering (5) 5
overexpression (5) 5
pharmacology & pharmacy (5) 5
physics (5) 5
processes of preparing such compositions (5) 5
protein kinase inhibitors - administration & dosage (5) 5
protein kinase inhibitors - adverse effects (5) 5
protein kinase inhibitors - pharmacokinetics (5) 5
protein-serine-threonine kinases - antagonists & inhibitors (5) 5
pyrimidines - adverse effects (5) 5
research (5) 5
spirits (5) 5
testing (5) 5
vinegar (5) 5
wine (5) 5
a kinase (4) 4
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - therapeutic use (4) 4
azepines - administration & dosage (4) 4
cell cycle (4) 4
corrosion inhibitors (4) 4
derivatives (4) 4
dose-response relationship, drug (4) 4
genetic aspects (4) 4
inhibition (4) 4
maximum tolerated dose (4) 4
medicine & public health (4) 4
mild-steel (4) 4
neoplasms - drug therapy (4) 4
neoplasms - pathology (4) 4
pharmacology/toxicology (4) 4
pyrimidines - administration & dosage (4) 4
treatment outcome (4) 4
adenocarcinoma - metabolism (3) 3
adenocarcinoma - pathology (3) 3
alloy (3) 3
aluminum (3) 3
animals (3) 3
antibodies (3) 3
antibody-drug conjugate (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
api (3) 3
atomic force microscopy (3) 3
aurora a (3) 3
aurora a kinase (3) 3
aurora kinase a - antagonists & inhibitors (3) 3
azepines - pharmacokinetics (3) 3
benzazepines - adverse effects (3) 3
benzazepines - pharmacokinetics (3) 3
cell biology (3) 3
cells (3) 3
cpg islands (3) 3
density functional theory (3) 3
dna methylation (3) 3
dosage and administration (3) 3
expression (3) 3
gene silencing (3) 3
guanylate cyclase (3) 3
heat-stable enterotoxin (3) 3
impedance data (3) 3
isotherms (3) 3
marker (3) 3
materials science, multidisciplinary (3) 3
metallurgy & metallurgical engineering (3) 3
methylation (3) 3
patients (3) 3
pharmacodynamic (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2014, Volume 32, Issue 1, pp. 44 - 50
Purpose Aurora A kinase (AAK) is overexpressed in aggressive lymphomas and can correlate with more histologically aggressive forms of disease. We therefore... 
SURVIVAL | IN-VITRO | ADVANCED SOLID TUMORS | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | ONCOLOGY | SYNTHETIC LETHAL | MYC | VINCRISTINE | MLN8237 | LEUKEMIA CELLS | NF-KAPPA-B | Burkitt Lymphoma - enzymology | Recurrence | Lymphoma, Follicular - drug therapy | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Aurora Kinase A - antagonists & inhibitors | Lymphoma, T-Cell - enzymology | Antineoplastic Agents - adverse effects | Adult | Female | Antineoplastic Agents - pharmacokinetics | Molecular Targeted Therapy - methods | Burkitt Lymphoma - drug therapy | Protein Kinase Inhibitors - pharmacokinetics | Azepines - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Drug Administration Schedule | Pyrimidines - administration & dosage | Lymphoma, Large B-Cell, Diffuse - enzymology | Lymphoma, Mantle-Cell - drug therapy | Treatment Outcome | Azepines - therapeutic use | Protein Kinase Inhibitors - administration & dosage | Lymphoma, T-Cell - drug therapy | Lymphoma, Mantle-Cell - enzymology | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Lymphoma, Follicular - enzymology | Aged | Azepines - pharmacokinetics | Azepines - administration & dosage | Hema13 | ORIGINAL REPORTS
Journal Article
Industrial & Engineering Chemistry Research, ISSN 0888-5885, 05/2013, Volume 52, Issue 20, pp. 6617 - 6632
Schiff base N,N′-bis(2-hydroxyethoxyacetophenone)-2,2-dimethyl-1,2-propanediimine (H2(hppnptn)) as corrosion inhibitor for API 5L grade B low carbon steel in... 
ENGINEERING, CHEMICAL | ALUMINUM | SCHIFF-BASE COMPOUNDS | AC-IMPEDANCE | ELECTRONEGATIVITY | FRAGRAN LEAVES EXTRACT | PARAMETERS | DENSITY-FUNCTIONAL THEORY | MILD-STEEL | DERIVATIVES | IMPEDANCE DATA
Journal Article
Journal of Materials Science and Technology, ISSN 1005-0302, 03/2014, Volume 30, Issue 3, pp. 239 - 252
The electrochemical behavior of low carbon steel (API 5L grade B) in 1mol/L HCl solution with different concentrations of... 
Atomic force microscopy | Corrosion | Density functional theory | Inhibitor | Impedance
Journal Article
材料科学技术学报:英文版, ISSN 1005-0302, 2016, Volume 32, Issue 11, pp. 1152 - 1160
Epoxy zinc rich coatings containing clay nanoparticles were prepared and the effect of clay content on the cathodic protection performance of the coatings was... 
富锌涂料 | 环氧涂层 | 电化学阻抗谱 | 防腐性能 | 纳米粒子 | 透射电子显微镜 | 纳米粘土 | 浸泡试验 | Epoxy coatings | Cathodic protection | Zinc rich | Clay | Impedance | MECHANISM | MATERIALS SCIENCE, MULTIDISCIPLINARY | METALLURGY & METALLURGICAL ENGINEERING | PIGMENTS | EIS | PAINTS | SPECTROSCOPY | IMPROVEMENT | MICACEOUS IRON-OXIDE | ANTICORROSION PERFORMANCE
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 12/2016, Volume 140, Issue 12, pp. 1397 - 1403
Context.- Excision repair cross-complementation 1 (ERCC1) is a key enzyme in nuclear excision repair pathway and has a critical role in helping remove DNA... 
MEDICINE, RESEARCH & EXPERIMENTAL | PATHOLOGY | CHEMOTHERAPY | EXPRESSION PREDICTS | CELL LUNG-CANCER | EXCISION-REPAIR | BREAST-CANCER | CISPLATIN | PROTEIN EXPRESSION | LOCALLY ADVANCED HEAD | MEDICAL LABORATORY TECHNOLOGY | DNA-REPAIR | AMERICAN-SOCIETY | Immunohistochemistry | Neoplasms - metabolism | Antibody Specificity | Endonucleases - genetics | Adenocarcinoma - pathology | Humans | Lung Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Neoplasm Proteins - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - diagnosis | Neoplasms - diagnosis | Endonucleases - metabolism | Neoplasm Proteins - metabolism | Head and Neck Neoplasms - metabolism | DNA-Binding Proteins - metabolism | Adenocarcinoma - metabolism | Sensitivity and Specificity | Biomarkers, Tumor - metabolism | Female | Clone Cells | Ovarian Neoplasms - metabolism | Carcinoma - pathology | Neoplasm Proteins - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Reproducibility of Results | DNA-Binding Proteins - antagonists & inhibitors | Endonucleases - antagonists & inhibitors | Ovarian Neoplasms - diagnosis | Carcinoma, Non-Small-Cell Lung - metabolism | Carcinoma - diagnosis | DNA-Binding Proteins - genetics | Head and Neck Neoplasms - pathology | Adenocarcinoma - diagnosis | Cell Line, Tumor | Head and Neck Neoplasms - diagnosis | Biomarkers, Tumor - genetics | Antibodies, Monoclonal - metabolism | Carcinoma - metabolism | Lung Neoplasms - diagnosis | Neoplasms - pathology | Cohort Studies | Viral antibodies | Medical research | Enzymes | Chemotherapy | Medicine, Experimental | Antibodies | Genetic aspects | Health aspects | Formaldehyde | Cancer
Journal Article
Journal of Materials Science & Technology, ISSN 1005-0302, 03/2014, Volume 30, Issue 3, pp. 239 - 252
The electrochemical behavior of low carbon steel (API 5L grade B) in 1 mol/L HCl solution with different concentrations of... 
Atomic force microscopy | Density functional theory | Inhibitor | Corrosion | Impedance | PART I | TOTAL ENERGIES | BEHAVIOR | MATERIALS SCIENCE, MULTIDISCIPLINARY | METALLURGY & METALLURGICAL ENGINEERING | HYDROCHLORIC-ACID SOLUTION | IRON | MILD-STEEL | LOW-CARBON STEEL | SET MODEL CHEMISTRY | ALLOY | DERIVATIVES
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 03/2015, Volume 55, Issue 3, pp. 336 - 347
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2018, Volume 13, Issue 1, p. e0191046
Guanylyl cyclase C (GCC) is a cell-surface protein that is expressed by normal intestinal epithelial cells, more than 95% of metastatic colorectal cancers... 
LIVER METASTASES | BREAST-CANCER | DRUG CONJUGATE | HEAT-STABLE ENTEROTOXIN | TAXANE RESISTANCE | MULTIDISCIPLINARY SCIENCES | PANCREATIC-CANCER | BRENTUXIMAB VEDOTIN | ECTOPIC EXPRESSION | SPINDLE ASSEMBLY CHECKPOINT | METASTATIC COLORECTAL-CANCER
Journal Article
Materials Research, ISSN 1516-1439, 08/2015, Volume 18, Issue 4
The formation and corrosion performance of zinc phosphate coating on carbon steel at different temperatures and immersion times was studied. The corrosion... 
Corrosion resistance | Corrosion prevention | Corrosion | Conversion coating | Carbon steels | Coating | Immersion | Protective coatings
Journal Article
Industrial & Engineering Chemistry Research, ISSN 0888-5885, 05/2013, Volume 52, Issue 20, pp. 6617 - 6632-6617-6632
Schiff base N,N'-bis(2-hydroxyethoxyacetophenone)-2,2-dimethyl-1,2-propa nediimine (H sub(2)(hppnptn)) as corrosion inhibitor for API 5L grade B low carbon... 
Corrosion inhibitors | Adsorption | Isotherms | Low carbon steels | Surface chemistry | API | Inhibition | Charge distribution
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2012, Volume 127, Issue 1, pp. 63 - 69
Journal Article
Investigational New Drugs, ISSN 0167-6997, 10/2017, Volume 35, Issue 5, pp. 634 - 641
Background This phase II open-label, multicenter study evaluated the efficacy, safety, and tolerability of TAK-264 in previously treated patients with advanced... 
Medicine & Public Health | Antibodies/immunoconjugates | Oncology | Antibody immunotherapy | Antibody–drug conjugate | Phase II trials_Pancreatic cancers: Pancreas | Pharmacology/Toxicology | TAK-264 | Guanylyl cyclase C | CELLS | HEAT-STABLE ENTEROTOXIN | MARKER | GCC | PROLIFERATION | TUMORS | GEMCITABINE | ONCOLOGY | COLORECTAL-CANCER | PHARMACOLOGY & PHARMACY | LIGAND | RECEPTORS | Antibody-drug conjugate | Pancreatic Neoplasms - metabolism | Humans | Middle Aged | Receptors, Enterotoxin - metabolism | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Adenocarcinoma - drug therapy | Pancreatic Neoplasms - drug therapy | Adenocarcinoma - metabolism | Aged, 80 and over | Immunoconjugates - therapeutic use | Adult | Female | Aged | Antimitotic agents | Complications and side effects | Pancreatic cancer | Monoclonal antibodies | Dosage and administration | Research | Antineoplastic agents | Drug therapy | Genetic aspects | Antibody-drug conjugates | Adenocarcinoma | Slopes | Intravenous administration | Toxicity | Metastasis | Guanylate cyclase | Metastases | Infusion | Vomiting | Quality | Safety management | Safety | Intravenous infusion | Toxic diseases | Pancreas | Neutropenia | Appetite | Fatigue | Nausea | Gastrointestinal tract | Pharmacology | Patients | Studies | Asthenia | Alopecia | Index Medicus
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 4/2011, Volume 67, Issue 4, pp. 945 - 954
Aurora A kinase is critical in assembly and function of the mitotic spindle. It is overexpressed in various tumor types and implicated in oncogenesis and tumor... 
Pharmacodynamics | MLN8054 | Aurora A kinase | Medicine & Public Health | Oncology | Cancer Research | Pharmacology/Toxicology | Pharmacokinetics | Dose-limiting toxicity | PROGNOSIS | SMALL-MOLECULE INHIBITOR | FAMILY | OVEREXPRESSION | GENE | ONCOLOGY | CENTROSOME AMPLIFICATION | MLN8237 | PHARMACOLOGY & PHARMACY | REGULATORS | EXPRESSION | Disorders of Excessive Somnolence - chemically induced | Benzazepines - adverse effects | Humans | Middle Aged | Half-Life | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Dose-Response Relationship, Drug | Young Adult | Central Nervous System Stimulants - therapeutic use | Antineoplastic Agents - adverse effects | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Benzhydryl Compounds - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Drug Administration Schedule | Administration, Oral | Aurora Kinases | Benzazepines - pharmacokinetics | Neoplasms - drug therapy | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Methylphenidate - therapeutic use | Aged | Benzazepines - administration & dosage | Neoplasms - pathology | Development and progression | Care and treatment | Research | Oncology, Experimental | Cancer | Index Medicus | pharmacokinetics | dose-limiting toxicity | pharmacodynamics
Journal Article
Investigational New Drugs, ISSN 0167-6997, 4/2017, Volume 35, Issue 2, pp. 235 - 241
Journal Article